Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30077740HIVENSG00000131844.17protein_codingMCCC2NoNo64087Q9HCC0
TVIS30078573HIVENSG00000131844.17protein_codingMCCC2NoNo64087Q9HCC0
TVIS30076673HIVENSG00000131844.17protein_codingMCCC2NoNo64087Q9HCC0
TVIS30062400HIVENSG00000131844.17protein_codingMCCC2NoNo64087Q9HCC0
TVIS30062401HIVENSG00000131844.17protein_codingMCCC2NoNo64087Q9HCC0
TVIS20000752HPVENSG00000131844.17protein_codingMCCC2NoNo64087Q9HCC0
TVIS44031722HTLV-1ENSG00000131844.17protein_codingMCCC2NoNo64087Q9HCC0
TVIS44022489HTLV-1ENSG00000131844.17protein_codingMCCC2NoNo64087Q9HCC0
TCGA Plot Options
Drug Information
GeneMCCC2
DrugBank IDDB00121
Drug NameBiotin
Target IDBE0000072
UniProt IDQ9HCC0
Regulation Typecofactor
PubMed IDs16707089; 17266990; 17254330; 17659996; 16772434
CitationsSantoro N, Brtva T, Roest SV, Siegel K, Waldrop GL: A high-throughput screening assay for the carboxyltransferase subunit of acetyl-CoA carboxylase. Anal Biochem. 2006 Jul 1;354(1):70-7. Epub 2006 May 3.@@de Queiroz MS, Waldrop GL: Modeling and numerical simulation of biotin carboxylase kinetics: implications for half-sites reactivity. J Theor Biol. 2007 May 7;246(1):167-75. Epub 2006 Dec 28.@@Ludke A, Kramer R, Burkovski A, Schluesener D, Poetsch A: A proteomic study of Corynebacterium glutamicum AAA+ protease FtsH. BMC Microbiol. 2007 Jan 25;7:6.@@Jitrapakdee S, Surinya KH, Adina-Zada A, Polyak SW, Stojkoski C, Smyth R, Booker GW, Cleland WW, Attwood PV, Wallace JC: Conserved Glu40 and Glu433 of the biotin carboxylase domain of yeast pyruvate carboxylase I isoenzyme are essential for the association of tetramers. Int J Biochem Cell Biol. 2007;39(11):2120-34. Epub 2007 Jun 27.@@Hassan YI, Zempleni J: Epigenetic regulation of chromatin structure and gene function by biotin. J Nutr. 2006 Jul;136(7):1763-5.
GroupsApproved; Investigational; Nutraceutical
Direct ClassificationBiotin and derivatives
SMILES[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2
PathwaysMitochondrial Complex II Deficiency; 3-Methylglutaconic Aciduria Type III; 2-Ketoglutarate Dehydrogenase Complex Deficiency; 4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency; Isovaleric Aciduria; Pyruvate Carboxylase Deficiency; Warburg Effect; Isobutyryl-CoA Dehydrogenase Deficiency; Biotin Metabolism; Fructose-1,6-diphosphatase Deficiency; Methylmalonic Aciduria Due to Cobalamin-Related Disorders; Propionic Acidemia; Transfer of Acetyl Groups into Mitochondria; Malonic Aciduria; 2-Hydroxyglutric Aciduria (D and L Form); 3-Methylcrotonyl-CoA Carboxylase Deficiency Type I; Congenital Lactic Acidosis; 3-Hydroxy-3-methylglutaryl-CoA Lyase Deficiency; Fumarase Deficiency; Succinic Semialdehyde Dehydrogenase Deficiency; Alanine Metabolism; Methylmalonic Aciduria; 3-Methylglutaconic Aciduria Type IV; Lactic Acidemia; Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease; Primary Hyperoxaluria Type I; Triosephosphate Isomerase; The Oncogenic Action of 2-Hydroxyglutarate; Valine, Leucine, and Isoleucine Degradation; Maple Syrup Urine Disease
PharmGKBPA448625
ChEMBLCHEMBL857